Background and aims: Conjunctival squamous cell carcinoma (CSCC) varies in inci-
| INTRODUCTION
Conjunctival squamous cell carcinoma (CSCC), a subset of ocular surface squamous carcinoma, is a cancer of the eye with an incidence rate of 0 to 1 case per 100 000 per year globally. 1 In the United States, this cancer typically effects elderly men (median age of 77) with high levels of ultraviolet (UV) exposure. 2, 3 In fact, Newton et al showed that the incidence of CSCC increased by 49% for every 10°decrease in latitude, supporting the role of UV exposure as a major risk factor. 4 Consistent with this finding, there are higher incidence rates of CSCC in equatorial areas of sub-Saharan Africa than in the rest of the world (0-5.3 cases per 100 000 vs 0-1 case per 100 000, respectively). 5 More recently, studies have also noted an apparent trend of increasing incidence of CSCC in sub-Saharan Africa. For example, in Uganda, there were four cases of CSCC reported between 1960 and 1971 and 66 cases 6, 7 reported between 1994 and 1997. Even accounting for better access to health care and increasing reporting of cancer in hospitalbased registries, these differences appear disproportionately larger than increased reporting alone would predict. In light of relatively small increase in levels of UV radiation exposure in the region, such increase in incidence has been putatively associated with the onset of the AIDS epidemic. 5, 8 Consistent with the parallel increases in the incidence of both HIV and CSCC, a study also observed twelvefold greater risk of developing CSCC in patients infected with HIV. 9 Although relationships have been drawn between CSCC and HIV/AIDS in countries in East Africa like Kenya and Uganda, 6, 7, [10] [11] [12] [13] very few studies on CSCC in West Africa have been published. Additionally, while a relationship between CSCC and HIV/AIDS has been established in sub-Saharan Africa, the pathogenesis and natural history of CSCC cases in HIV+ patients in Western Africa have not yet been described, limiting our understanding of causative risk factors for the disease. One potential causative factor is infection with human papillomavirus (HPV), although the literature has shown disparate findings regarding the role of HPV in the pathogenesis of CSCC in HIV+ patients. In one set of studies done in both Africa and the United States, evidence of HPV infection was found in most CSCC tumor samples. [13] [14] [15] [16] [17] [18] [19] [20] In contrast, another set of studies from Africa as well as from other regions of the world such as the United States, Germany, Brazil, and Mexico has found no evidence of HPV in CSCC. 10, [21] [22] [23] [24] In addition, prognostic tumor biomarkers like cyclin D, p16, estimated glomerular filtration rate (EGFR), and p53 have been described in CSCC in the United States, but these are not well studied in CSCC in Africa. [25] [26] [27] This study seeks to establish the clinical characteristics of HIV+ 
| Marker detection by immunohistochemistry
Fifty-nine CSCC tumors in paraffin-embedded block or slides from
Ghanaian patients seen and/or treated at KATH were analyzed at 
| Statistical analysis
The data were analyzed with SPSS software, version 23.0 (SPSS, Inc., Chicago, IL), and a chi-squared analysis was used on categorical data 
| Clinical characteristics and natural history of conjunctival cancers in Ghana
Patients first presented to the hospital 3 weeks to 5 years after the initial symptom was noted (median: 1 y; interquartile range [IQR]:
0.35-1.5). After diagnosis, the most common symptoms patients complained of are shown in Figure 2 . The different types of discharge patient was known to be deceased. there is a lower percentage of females in this subset than in the entire FIGURE 2 Symptoms on initial presentation. Patient symptoms on initial presentation with conjunctival squamous cell carcinoma (CSCC). The most common complaint was the presence of a mass (n = 43) followed by discharge (n = 35), pain (n = 26), swelling (n = 19), vision changes (n = 19), eye discoloration (n = 18), and itching (n = 15) Therefore, p16 immunostaining did not seem to correlate with HPV status in our CSCC cohort, as seen in Figure 4 . However, these results once again must be interpreted with caution as only a small subset of patients had tumors available for testing and the samples that were successfully analyzed did not always yield results for every biomarker.
| Treatment modality and recurrences

| DISCUSSION
This study was the first to assess the demographics, clinical character- Additionally, other studies of CSCC in Africa report a higher rate of HIV infection in patients with CSCC than in the general population, The P values of biomarkers compared with clinical characteristics are shown. A Bonferroni correction was applied for multiple testing (six attributes, P < 0.0083 required for significance). We found no statistically significant relationship between any of the tumor biomarkers and clinical characteristics.
Abbreviation: EGFR, Epidermal growth factor receptor. Chi-squared analysis was used to compare individual biomarkers and HIV status, sex, grouped stage (stages 1 + 2 vs stages 3 + 4), smoking behavior, and alcohol use. Logistic regression was used to compare biomarkers to age.
FIGURE 3
Presence of tumor biomarkers stratified by HIV status. The results of the tumor biomarker analysis are graphed and stratified by HIV status. All 59 CSCC samples were analyzed for p53, p16, EGFR, and cyclin D, but not every sample yielded a result for every biomarker. As such, the number of samples within each biomarker graph does not always add up to 59. We observed no significant relationship between any of the tumor biomarkers and HIV status, sex, or stage of the tumor. However, only 27 samples had corresponding clinical data ranging from 50% to 76.9% of the CSCC population with HIV infection. 5, [37] [38] [39] 42 This was supported by the findings in our study, as 32/64 (50%) of the patients with CSCC are HIV+ while the incidence of HIV infection 43 in Ghana is 1.47%.
In the United States, CSCC is seen two to three times more in men than women, and it presents at a median age of 77 years old. 3 However, in Ghana, over half (51.3%) of the patients diagnosed with CSCC are female, and the median age is 46.5 years old, with some patients presenting as young as 20 years old. This is also consistent with some studies of CSCC performed in Eastern Africa that report that over half of their CSCC cohorts are female, with a mean age at diagnosis [37] [38] [39] [40] 42, 44 in the 30s to 50s. Additionally, in the general Gha- The CSCC cohort reported 3.1% current smokers and 7.8% former smokers, which closely mirrors the general Ghanaian population data, 46 suggesting that smoking is not a major risk factor in the pathogenesis of CSCC in Ghana. In the United States, smoking and alcohol use are important risk factors for HNSCC, 47, 48 but there does not seem to be an increased uptake among patients with CSCC in Ghana.
We observed a significant relationship between smoking and HIV infection (chi-squared test, P = 0.029) as well as between alcohol use and HIV infection (chi-squared test, P = 0.041) in this cohort. However, the patient charts at KATH seldom reported detailed alcohol exposures making it difficult to differentiate alcohol use from abuse.
FIGURE 4
Immunostaining does not correlate with human papillomavirus (HPV) status in our conjunctival squamous cell-carcinoma (CSCC) cohort. Four independent replicates of immunohistochemical staining with parallel positive and negative control tissue were performed per sample, and representative images from p16 and p53 staining from an HPV positive case and HPV negative case are shown. We expected to observe p53 expression in the HPV negative cases and p53 suppression in HPV positive cases as p53 is known to be suppressed in HPV infection. Indeed, p53 expression is seen in the HPV negative cases, and p53 suppression is seen in the HPV positive case. Additionally, we expected to see p16 expression in the HPV positive case as p16 is a frequent marker of HPV infection in cells. However, p16 is negative in both the HPV positive case and HPV negative case. It is possible that p16 expression is not an accurate marker for HPV infection in these samples
Additionally, this analysis is limited by the fact that only 35/64 (54.7%) of patients had information on alcohol use recorded and only 34/64 (53.1%) had smoking data available, leaving the data set open to selection bias. Analysis with more complete patient data is required to draw further conclusions.
The clinical presentation of CSCC in HIV+ and HIV− patients in Ghana was also examined in this study. Most patients had symptoms for 1 year before presentation, and the most common symptom at presentation was a mass. After diagnosis, the most common symptoms included discharge, eye pain, and headache. This presentation is consistent with CSCC in the United States as well as in Africa. 26, 38, 39, 42, 44 Additionally, 16/64 (25%) of the Ghanaian cohort had at least one constitutional symptom, and we observed a significant relationship between constitutional symptoms and HIV infection (chi-squared test, P = 0.011). Conversely, constitutional symptoms are rare in patients with CSCC in the United States and have not previously been reported in Africa. 26 HIV infection could cause a more systemic and aggressive manifestation of CSCC. However, HIV+ patients are also more susceptible to infection, so the reported constitutional symptoms could be related to an underlying chronic infection rather than the CSCC.
Recurrence after initial treatment is common in both the United
States and Ghana because of ambiguous tumor margins as well as desire to preserve the eye. 49 
| CONCLUSION
In conclusion, this study highlighted the equal incidence of CSCC in males and females in Ghana as well as the 15.6-fold higher HIV infection rate in the CSCC cohort compared with the general Ghanaian population. We also found a significant relationship between female sex and HIV infection in this cohort. Smoking, a known risk in upper aerodigestive-tract HNSCC in the United States, has no greater incidence in CSCC cohort than in the general Ghanaian population, suggesting that smoking is not a major risk factor in CSCC in Ghana. HIV status is noted and fresh tissue from their tumor sample is collected for biomarker analysis.
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